Unibest

Pharmaceutical intermediates

Ensitrelvir(S-217622) Intermediates

5 pharmaceutical intermediates for Ensitrelvir(S-217622). Indication: SARS-CoV-2 infection.

提交项目All intermediates

About Ensitrelvir(S-217622)

Originator
Shionogi & Co., Ltd.
Indication
SARS-CoV-2 infection

Available intermediates

5 intermediates currently listed for Ensitrelvir(S-217622). Request specifications, documentation or a quotation for any item below.

Ensitrelvir(S-217622) intermediates
Product NameCAS No.Molecular FormulaPhysical Properties
S-ethylisothiourea hydrobromide1071-37-0//
1,3,5-Triazine-2,4(1H,3H)-dione, 3-(1,1-dimethylethyl)-6-(ethylthio)-1360105-53-8//
6-(Ethylthio)-1-(2,4,5-trifluorobenzyl)-1,3,5-triazine-2,4(1H,3H)-dione2771355-74-7//
3-(chloromethyl)-1-methyl-1H-1,2,4-Triazole hydrochloride135206-76-7//
6-chloro-2-methyl-2H-indazol-5-amine1893125-36-4//

Other programs under E

Edoxaban tosylate monohydrateElacestrantElagolix SodiumEldecalcitolElinzanetantElobixibatEltrombopagEltrombopag Olamine

Building toward Ensitrelvir(S-217622)?

Tell us the step you need covered and the specification you are filing against. We will confirm supply, documentation and lead time.

提交项目 联系团队

我们能如何帮助您？

获取最新活动与法规动态洞察

直接发送到您的邮箱

在此获取行业洞察与 Unibest 动态

联系我们 →